Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 223,914 |
|
|||||
| News | (1) | ||||||
| Day High | 8.18 | Low High |
|||||
| Day Low | 7.6016 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.11 | 1.37% | 8.11 | 19:57:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.18 | 7.6016 | 8.18 | 7.73 | 8.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,492 | 223,914 | $ 7.77 | $ 1,739,003 | - | 4.004 - 40.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:08:10 | 20 | $ 8.11 | USD |
Outlook Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 100.33M | 13.01M | - | 0 | -58.98M | -4.53 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Outlook Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.60 | 8.91 | 7.6016 | 8.27 | 239,664 | -0.49 | -5.70% |
| 1 Month | 9.09 | 9.34 | 7.6016 | 8.47 | 235,224 | -0.98 | -10.78% |
| 3 Months | 9.00 | 12.8499 | 5.0401 | 8.54 | 1,246,090 | -0.89 | -9.89% |
| 6 Months | 9.80 | 12.8499 | 5.0401 | 8.55 | 1,659,248 | -1.69 | -17.24% |
| 1 Year | 22.80 | 40.60 | 4.004 | 10.70 | 4,032,523 | -14.69 | -64.43% |
| 3 Years | 42.80 | 65.40 | 4.004 | 20.05 | 2,123,484 | -34.69 | -81.05% |
| 5 Years | 25.60 | 85.20 | 4.004 | 26.57 | 2,135,478 | -17.49 | -68.32% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
